By Robbin Laird and Ed Timperlake The United States and a number of key allies have begun to focus significant attention on reworking the supply chain in key industries associated with imports from China. As Dr. Harald Malmgren recently noted: “Much new industrial thinking is under way how the next phase of manufacturing should be … Continue reading Dealing with the Chinese Challenge: The Case of the Pharmaceutical Industry